ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,568 | +4.7% | 58,492 | +13.9% | 0.00% | – |
| Q2 2023 | $82,714 | -91.5% | 51,375 | -84.6% | 0.00% | – |
| Q1 2023 | $970,303 | -16.7% | 334,587 | -5.8% | 0.00% | – |
| Q4 2022 | $1,165,289 | +258.6% | 355,271 | +314.0% | 0.00% | – |
| Q3 2022 | $325,000 | +2.2% | 85,814 | +110.2% | 0.00% | – |
| Q2 2022 | $318,000 | -86.3% | 40,818 | -83.6% | 0.00% | -100.0% |
| Q1 2022 | $2,316,000 | -40.2% | 249,283 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $3,871,000 | +59.8% | 245,594 | +81.5% | 0.00% | 0.0% |
| Q3 2021 | $2,422,000 | +390.3% | 135,320 | +325.5% | 0.00% | – |
| Q2 2021 | $494,000 | -66.5% | 31,803 | -69.0% | 0.00% | – |
| Q1 2021 | $1,474,000 | +2167.7% | 102,697 | +3011.1% | 0.00% | – |
| Q4 2020 | $65,000 | +32.7% | 3,301 | -13.9% | 0.00% | – |
| Q3 2020 | $49,000 | -31.9% | 3,835 | -22.9% | 0.00% | – |
| Q2 2020 | $72,000 | -15.3% | 4,976 | -50.0% | 0.00% | – |
| Q1 2020 | $85,000 | -86.3% | 9,958 | -73.6% | 0.00% | – |
| Q4 2019 | $621,000 | 0.0% | 37,708 | -14.2% | 0.00% | – |
| Q3 2019 | $621,000 | +787.1% | 43,970 | +1158.8% | 0.00% | – |
| Q2 2019 | $70,000 | +6.1% | 3,493 | +111.7% | 0.00% | – |
| Q1 2019 | $66,000 | -17.5% | 1,650 | -28.7% | 0.00% | – |
| Q4 2018 | $80,000 | -89.5% | 2,314 | -87.4% | 0.00% | – |
| Q3 2018 | $760,000 | +2433.3% | 18,394 | +2143.2% | 0.00% | – |
| Q2 2018 | $30,000 | -99.3% | 820 | -99.2% | 0.00% | -100.0% |
| Q1 2018 | $4,016,000 | +17360.9% | 102,974 | +7970.1% | 0.00% | – |
| Q4 2017 | $23,000 | +35.3% | 1,276 | +20.3% | 0.00% | – |
| Q3 2017 | $17,000 | – | 1,061 | +5205.0% | 0.00% | – |
| Q2 2017 | $0 | – | 20 | +17.6% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 17 | -99.8% | 0.00% | – |
| Q4 2016 | $120,000 | -18.9% | 8,420 | +22.2% | 0.00% | – |
| Q3 2016 | $148,000 | -12.4% | 6,889 | -8.3% | 0.00% | – |
| Q2 2016 | $169,000 | +24.3% | 7,516 | +4.9% | 0.00% | – |
| Q1 2016 | $136,000 | -85.3% | 7,165 | -79.6% | 0.00% | -100.0% |
| Q4 2015 | $925,000 | +697.4% | 35,046 | +853.6% | 0.00% | – |
| Q3 2015 | $116,000 | -26.6% | 3,675 | +23.2% | 0.00% | – |
| Q2 2015 | $158,000 | +276.2% | 2,984 | +198.4% | 0.00% | – |
| Q1 2015 | $42,000 | +44.8% | 1,000 | -8.6% | 0.00% | – |
| Q4 2014 | $29,000 | – | 1,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |